ArticleCancers2021

Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.

Marina Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.